LAMP1 and colorectal cancer: Furthermore, the inhibition of lysosomal functions by mefloquine reduces the levels of LAMP1/2 as well as the early and late endosome markers Rab5 and Rab7, respectively, leading to the elimination of CSCs via dysfunctional mitochondrial clearance in a colorectal cancer model [240].